HEXAOM (ALHEX.PA) Fundamental Analysis & Valuation

EPA:ALHEX • FR0004159473

Current stock price

30.7 EUR
+1.5 (+5.14%)
Last:

This ALHEX.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ALHEX.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALHEX was profitable.
  • In the past year ALHEX has reported a negative cash flow from operations.
  • ALHEX had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years ALHEX had a positive operating cash flow.
ALHEX.PA Yearly Net Income VS EBIT VS OCF VS FCFALHEX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

  • The Return On Assets of ALHEX (1.46%) is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of 3.94%, ALHEX is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • ALHEX has a Return On Invested Capital of 3.70%. This is comparable to the rest of the industry: ALHEX outperforms 47.06% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ALHEX is in line with the industry average of 10.09%.
  • The last Return On Invested Capital (3.70%) for ALHEX is well below the 3 year average (8.77%), which needs to be investigated, but indicates that ALHEX had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.46%
ROE 3.94%
ROIC 3.7%
ROA(3y)1.03%
ROA(5y)1.76%
ROE(3y)1.4%
ROE(5y)4.65%
ROIC(3y)8.77%
ROIC(5y)8.58%
ALHEX.PA Yearly ROA, ROE, ROICALHEX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

  • With a Profit Margin value of 1.46%, ALHEX perfoms like the industry average, outperforming 44.12% of the companies in the same industry.
  • ALHEX's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 2.30%, ALHEX is doing worse than 61.76% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ALHEX has declined.
  • The Gross Margin of ALHEX (21.14%) is worse than 79.41% of its industry peers.
  • In the last couple of years the Gross Margin of ALHEX has remained more or less at the same level.
Industry RankSector Rank
OM 2.3%
PM (TTM) 1.46%
GM 21.14%
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y-3.63%
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5YN/A
ALHEX.PA Yearly Profit, Operating, Gross MarginsALHEX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ALHEX.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALHEX is creating some value.
  • The number of shares outstanding for ALHEX remains at a similar level compared to 1 year ago.
  • The debt/assets ratio for ALHEX has been reduced compared to a year ago.
ALHEX.PA Yearly Shares OutstandingALHEX.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M
ALHEX.PA Yearly Total Debt VS Total AssetsALHEX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • ALHEX has an Altman-Z score of 2.10. This is not the best score and indicates that ALHEX is in the grey zone with still only limited risk for bankruptcy at the moment.
  • ALHEX has a Altman-Z score (2.10) which is comparable to the rest of the industry.
  • ALHEX has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
  • With a Debt to Equity ratio value of 0.40, ALHEX perfoms like the industry average, outperforming 55.88% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 2.1
ROIC/WACC0.54
WACC6.92%
ALHEX.PA Yearly LT Debt VS Equity VS FCFALHEX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

  • A Current Ratio of 1.31 indicates that ALHEX should not have too much problems paying its short term obligations.
  • ALHEX's Current ratio of 1.31 is in line compared to the rest of the industry. ALHEX outperforms 41.18% of its industry peers.
  • ALHEX has a Quick Ratio of 1.31. This is a bad value and indicates that ALHEX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.99, ALHEX is in the better half of the industry, outperforming 67.65% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 0.99
ALHEX.PA Yearly Current Assets VS Current LiabilitesALHEX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ALHEX.PA Growth Analysis

3.1 Past

  • The earnings per share for ALHEX have decreased strongly by -68.84% in the last year.
  • Measured over the past years, ALHEX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -13.22% on average per year.
  • ALHEX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -30.53%.
  • The Revenue has been decreasing by -9.93% on average over the past years.
EPS 1Y (TTM)-68.84%
EPS 3Y-13.22%
EPS 5YN/A
EPS Q2Q%-48.59%
Revenue 1Y (TTM)-30.53%
Revenue growth 3Y-9.93%
Revenue growth 5YN/A
Sales Q2Q%-26.54%

3.2 Future

  • ALHEX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 37.93% yearly.
  • ALHEX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.02% yearly.
EPS Next Y2.44%
EPS Next 2Y37.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.32%
Revenue Next 2Y2.8%
Revenue Next 3YN/A
Revenue Next 5Y3.02%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALHEX.PA Yearly Revenue VS EstimatesALHEX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
ALHEX.PA Yearly EPS VS EstimatesALHEX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

4

4. ALHEX.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 23.44, which indicates a rather expensive current valuation of ALHEX.
  • ALHEX's Price/Earnings is on the same level as the industry average.
  • When comparing the Price/Earnings ratio of ALHEX to the average of the S&P500 Index (24.89), we can say ALHEX is valued inline with the index average.
  • Based on the Price/Forward Earnings ratio of 7.64, the valuation of ALHEX can be described as very cheap.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ALHEX indicates a somewhat cheap valuation: ALHEX is cheaper than 64.71% of the companies listed in the same industry.
  • ALHEX is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 23.44
Fwd PE 7.64
ALHEX.PA Price Earnings VS Forward Price EarningsALHEX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 64.71% of the companies in the same industry are more expensive than ALHEX, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.6
ALHEX.PA Per share dataALHEX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • ALHEX's earnings are expected to grow with 37.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)9.61
PEG (5Y)N/A
EPS Next 2Y37.93%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. ALHEX.PA Dividend Analysis

5.1 Amount

  • ALHEX has a Yearly Dividend Yield of 1.68%.
  • Compared to an average industry Dividend Yield of 3.16, ALHEX has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.89, ALHEX has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.68%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALHEX.PA Yearly Dividends per shareALHEX.PA Yearly Dividends per shareYearly Dividends per share 2025 2026 0.2 0.4 0.6

5.3 Sustainability

DP0%
EPS Next 2Y37.93%
EPS Next 3YN/A
ALHEX.PA Yearly Income VS Free CF VS DividendALHEX.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 20M -20M

More info and screens

Find the best dividend stocksShow peers with best dividend

ALHEX.PA Fundamentals: All Metrics, Ratios and Statistics

HEXAOM

EPA:ALHEX (3/27/2026, 7:00:00 PM)

30.7

+1.5 (+5.14%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)02-10
Earnings (Next)N/A
Inst Owners15.78%
Inst Owner ChangeN/A
Ins Owners2.84%
Ins Owner ChangeN/A
Market Cap213.06M
Revenue(TTM)617.81M
Net Income(TTM)9.04M
Analysts86.67
Price Target46.41 (51.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.68%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)16.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 23.44
Fwd PE 7.64
P/S 0.34
P/FCF N/A
P/OCF N/A
P/B 0.93
P/tB 2.1
EV/EBITDA 5.6
EPS(TTM)1.31
EY4.27%
EPS(NY)4.02
Fwd EY13.08%
FCF(TTM)-1.52
FCFYN/A
OCF(TTM)-0.85
OCFYN/A
SpS89.02
BVpS33.03
TBVpS14.6
PEG (NY)9.61
PEG (5Y)N/A
Graham Number31.2
Profitability
Industry RankSector Rank
ROA 1.46%
ROE 3.94%
ROCE 4.7%
ROIC 3.7%
ROICexc 6.23%
ROICexgc 17.99%
OM 2.3%
PM (TTM) 1.46%
GM 21.14%
FCFM N/A
ROA(3y)1.03%
ROA(5y)1.76%
ROE(3y)1.4%
ROE(5y)4.65%
ROIC(3y)8.77%
ROIC(5y)8.58%
ROICexc(3y)19.44%
ROICexc(5y)18.53%
ROICexgc(3y)71.44%
ROICexgc(5y)100.96%
ROCE(3y)11.34%
ROCE(5y)10.99%
ROICexgc growth 3Y-17.24%
ROICexgc growth 5YN/A
ROICexc growth 3Y-9.08%
ROICexc growth 5YN/A
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y-3.63%
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5YN/A
F-Score4
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA 2.97
Cap/Depr 27.37%
Cap/Sales 0.75%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.31
Quick Ratio 0.99
Altman-Z 2.1
F-Score4
WACC6.92%
ROIC/WACC0.54
Cap/Depr(3y)33.88%
Cap/Depr(5y)34.44%
Cap/Sales(3y)0.94%
Cap/Sales(5y)0.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.84%
EPS 3Y-13.22%
EPS 5YN/A
EPS Q2Q%-48.59%
EPS Next Y2.44%
EPS Next 2Y37.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.53%
Revenue growth 3Y-9.93%
Revenue growth 5YN/A
Sales Q2Q%-26.54%
Revenue Next Year-11.32%
Revenue Next 2Y2.8%
Revenue Next 3YN/A
Revenue Next 5Y3.02%
EBIT growth 1Y-50.48%
EBIT growth 3Y-15.33%
EBIT growth 5YN/A
EBIT Next Year75%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-136.13%
FCF growth 3Y-29.75%
FCF growth 5YN/A
OCF growth 1Y-114.31%
OCF growth 3Y-21.91%
OCF growth 5YN/A

HEXAOM / ALHEX.PA Fundamental Analysis FAQ

What is the fundamental rating for ALHEX stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALHEX.PA.


What is the valuation status for ALHEX stock?

ChartMill assigns a valuation rating of 4 / 10 to HEXAOM (ALHEX.PA). This can be considered as Fairly Valued.


How profitable is HEXAOM (ALHEX.PA) stock?

HEXAOM (ALHEX.PA) has a profitability rating of 4 / 10.


What are the PE and PB ratios of HEXAOM (ALHEX.PA) stock?

The Price/Earnings (PE) ratio for HEXAOM (ALHEX.PA) is 23.44 and the Price/Book (PB) ratio is 0.93.


Can you provide the financial health for ALHEX stock?

The financial health rating of HEXAOM (ALHEX.PA) is 4 / 10.